Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 2/3 Open-Label, Randomized, Active-Controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Than..
Sponsored by Merck Sharp & Dohme Corp.
$122.6K Funding
1 People
External
Related Topics
pediatric participants,
safety and tolerability,
efficacy,
pharmacokinetics
People
Lynn Gries
Principal Investigator (PI)
Surgery
﹒Associate Professor
